FeesSafety
Pluang+

SalesCloser reports 235% revenue growth, four US patents, and global expansion across eight countries.

Market News
10 Nov 2026, 14:20 WIB
GlobeNewsWire
View Source
Bullish
SalesCloser reports 235% revenue growth, four US patents, and global expansion across eight countries.

SalesCloser Technologies Ltd. announced a 235% revenue increase to $1.13 million for the nine months ending June 30, 2026, driven by expanded customer adoption across at least eight countries and multiple industries. The company secured four US patents with a fifth allowed, launched ten major product enhancements, and diversified revenue geographically with over one-third from outside North America. Key deployments span insurance, hospitality, social media, and software sectors, supported by partnerships with Twilio and others. SalesCloser's innovations, including AI sales agents and multilingual support, position it for continued growth in autonomous AI sales technology.

SalesCloser Technologies Ltd. reported strong growth and innovation. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 19:03 WIB: out of 150 priced US tech stocks, 45 rose and 99 fell. Notable movers include QUBT at USD 6.58 with a 4.08% decline, TTWO at USD 215.26 up 3.79%, and YOU at USD 56.86 up 3.21%.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
36 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
36 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
36 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
36 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App